Skip to main content
SpringerLink
Log in

Metastasenchirurgie beim Prostatakarzinom

Surgery for metastatic prostate cancer

  • Kurzübersichten
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1a–c

Literatur

  1. Robert Koch-Institut (Hrsg), Gesellschaft der epidemiologischen Krebsregister in Deutschland (Hrsg) (2015) Krebs in Deutschland 2011/2012. 10. Ausgabe. http://www.hamburg.de/contentblob/4334522/768450404f0adef88bbf42ca62b03975/data/krebs-in-deutschland.pdf. Zugegriffen: 1. Dez 2016

    Google Scholar 

  2. Froehner M, Hölscher T, Hakenberg OW, Wirth MP (2014) Treatment of bone metastases in urologic malignancies. Urol Int 93:249–256

    Article  CAS  PubMed  Google Scholar 

  3. Suardi N, Gandaglia G, Gallina A, Di Trapani E, Scattoni V, Vizziello D, Cucchiara V, Bertini R, Colombo R, Picchio M, Giovacchini G, Montorsi F, Briganti A (2015) Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years. Eur Urol 67:299–309

    Article  PubMed  Google Scholar 

  4. Perera M, Papa N, Christidis D, Wetherell D, Hofman MS, Murphy DG, Bolton D, Lawrentschuk N (2016) Sensitivity, specificity, and predictors of positive 68 Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: A systematic review and meta-analysis. Eur Urol 70(6):926–937. doi:10.1016/j.eururo.2016.06.021

    Article  PubMed  Google Scholar 

  5. Maurer T, Weirich G, Schottelius M, Weineisen M, Frisch B, Okur A, Kübler H, Thalgott M, Navab N, Schwaiger M, Wester HJ, Gschwend JE, Eiber M (2015) Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer. Eur Urol 68:530–534

    Article  PubMed  Google Scholar 

  6. Saluja R, Cheung P, Zukotynski K, Emmenegger U (2016) Disease volume and distribution as drivers of treatment decisions in metastatic prostate cancer: from chemohormonal therapy to stereotactic ablative radiotherapy of oligometastases. Urol Oncol 34:225–232

    Article  CAS  PubMed  Google Scholar 

  7. Deutsche Gesellschaft für Urologie (2016) Konsultationsfassung 2016. Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms. AWMF-Register-Nummer (034/022OL) Version 4.0 – Aktualisierung 2016. http://leitlinienprogramm-onkologie.de/uploads/tx_sbdownloader/LL_Prostata_Langversion_4_0_Konsultationsfassung_.pdf. Zugegriffen: 1. Dez 2016

    Google Scholar 

  8. Mottet N, Bellmunt J, Briers E, Bolla M, Cornford P, De Santis M, Henry A, Joniau S, Lam T, Mason MD, Matveev V, van der Poel H, van der Kwast TH, Rouvière O, Wiegel T (2016) EAU guideline on cancer. Update 2016. http://uroweb.org/guideline/prostate-cancer/. Zugegriffen: 1. Dez 2016

    Google Scholar 

  9. Heidenreich A, Moul JW, Shariat S, Karnes RJ (2016) Role of salvage lymph node dissection in prostate cancer. Curr Opin Urol 26:581–589

    Article  PubMed  Google Scholar 

  10. Lukovic J, Rodrigues G (2015) Complete PSA response following stereotactic ablative radiotherapy for a bony metastasis in the setting of castrate-resistant prostate cancer. Cureus 7:e365

    PubMed  PubMed Central  Google Scholar 

  11. Osmonov DK, Aksenov AV, Trick D, Naumann CM, Hamann MF, Faddan AA, Jünemann KP (2016) Cancer-specific and overall survival in patients with recurrent prostate cancer who underwent salvage extended pelvic lymph node dissection. BMC Urol 16:56

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Urologie, Universitätsklinikum „Carl Gustav Carus“ der Technischen Universität Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland

    M. Fröhner &  M. Wirth

Authors
  1. M. Fröhner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Wirth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Fröhner.

Ethics declarations

Interessenkonflikt

M. Fröhner und M. Wirth geben an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fröhner, M., Wirth, M. Metastasenchirurgie beim Prostatakarzinom. Urologe 56, 1017–1018 (2017). https://doi.org/10.1007/s00120-017-0373-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-017-0373-9

Search

Navigation